A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast CancerSrinivasan Madhusudan, Adrian L. Harris, Cheng Han et al.|Clinical Cancer Research|2004Cited by 204
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian CancerSrinivasan Madhusudan, Trivadi S. Ganesan, S. Muthuramalingam et al.|Journal of Clinical Oncology|2005Cited by 166
A phase II trial using etanercept, a recombinant tumour necrosis factor antagonist, in metastatic breast cancerFörster, Adrian L. Harris, Denis Talbot et al.|UCL Discovery (University College London)|2002Cited by 1